Can a patient with a history of kidney transplant and presenting with pharyngitis and upper respiratory tract infection be treated with amoxicillin (amoxicillin) clavulanate (clavulanic acid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: April 16, 2025 • View editorial policy

From the Guidelines

Kidney transplant patients should not take amoxicillin-clavulanate for a sore throat and common cold without consulting their transplant physician first. These symptoms typically indicate a viral infection, not a bacterial one, and antibiotics like amoxicillin-clavulanate are only effective against bacterial infections. Taking unnecessary antibiotics can lead to antibiotic resistance and potential side effects, such as diarrhea, rash, and more severe reactions like Stevens-Johnson syndrome or anaphylaxis, as reported in studies 1. Additionally, kidney transplant patients are on immunosuppressive medications that can interact with certain antibiotics and affect drug levels in the body.

The patient should contact their transplant team promptly about these symptoms, as even minor infections can become serious in immunocompromised individuals. The transplant team may recommend symptomatic treatment with rest, fluids, and over-the-counter medications that are safe with their specific transplant medications. If a bacterial infection is suspected, the transplant team will prescribe appropriate antibiotics considering the patient's kidney function and potential drug interactions with their immunosuppressive regimen. It's essential to note that the use of antibiotics should be based on stringent clinical criteria to establish the diagnosis of a bacterial infection, as outlined in guidelines for antimicrobial treatment 2, 3.

Some key points to consider include:

  • The potential for antibiotic-associated adverse events, which can range from mild to life-threatening 1
  • The importance of applying stringent clinical criteria to establish the diagnosis of a bacterial infection 1
  • The need to consider the patient's kidney function and potential drug interactions with their immunosuppressive regimen when prescribing antibiotics 2, 3
  • The recommendation for initial therapy for adult patients with mild disease, which includes amoxicillin/clavulanate, amoxicillin, cefpodoxime proxetil, cefuroxime axetil, or cefdinir 2
  • The recommendation for initial therapy for children with mild disease, which includes high-dose amoxicillin/clavulanate, amoxicillin, cefpodoxime proxetil, cefuroxime axetil, or cefdinir 3

From the FDA Drug Label

Adults and Pediatric Patients Upper Respiratory Tract Infections of the Ear, Nose, and Throat:Amoxicillin for oral suspension is indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Streptococcusspecies. (α-and β-hemolytic isolates only), Streptococcus pneumoniae, Staphylococcusspp., or Haemophilus influenzae.

The patient can take amoxicillin as treatment for a sore throat plus common cold, but only if the infection is proven or strongly suspected to be caused by bacteria. However, the provided drug labels do not specifically address the use of amoxicillin clavulanate in kidney transplant patients.

  • The labels only discuss the use of amoxicillin.
  • There is no information about amoxicillin clavulanate. Therefore, no conclusion can be drawn about the use of amoxicillin clavulanate in this specific patient population [4] [5].

From the Research

Kidney Transplant Patient Treatment

  • A kidney transplant patient with a sore throat and common cold may require antibiotic treatment, but the choice of antibiotic is crucial to avoid interactions with immunosuppressive medications.
  • The provided studies do not specifically address the use of amoxicillin-clavulanate in kidney transplant patients with a sore throat and common cold 6, 7, 8, 9, 10.
  • However, it is known that kidney transplant patients require careful management of immunosuppressive therapy to avoid rejection and prolong graft function 7, 8, 9, 10.
  • The use of certain antibiotics, such as macrolides, can interact with immunosuppressive medications like calcineurin inhibitors, increasing the risk of nephrotoxicity 6.
  • There is no direct evidence to suggest that amoxicillin-clavulanate is contraindicated in kidney transplant patients, but caution is advised when prescribing any medication to these patients due to the potential for drug interactions and complications 9, 10.

Considerations for Antibiotic Treatment

  • The choice of antibiotic should be based on the suspected or confirmed cause of the infection, as well as the patient's medical history and current medications 9, 10.
  • Kidney transplant patients may be more susceptible to infections due to immunosuppression, and antibiotic treatment should be guided by clinical judgment and laboratory results 7, 8, 9, 10.
  • It is essential to monitor kidney function and adjust antibiotic doses accordingly to minimize the risk of nephrotoxicity 6, 9, 10.

References

Guideline

antimicrobial treatment guidelines for acute bacterial rhinosinusitis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2004

Guideline

antimicrobial treatment guidelines for acute bacterial rhinosinusitis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2004

Research

Outcomes Following Macrolide Use in Kidney Transplant Recipients.

Canadian journal of kidney health and disease, 2019

Research

Immunosuppression Therapy in Kidney Transplantation.

The Urologic clinics of North America, 2022

Research

Management of Kidney Transplant Recipients by General Nephrologists: Core Curriculum 2019.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.